Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > TRX
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Bigboyoneon Oct 27, 2016 2:37pm
146 Views
Post# 25394125

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TRX

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TRXTottaly agree with Kuato here.
.Nothing but good news reports after good news reports coming out about ARALEZ,
& Lest we forget Tribute was a profitable little co, before the merge..
The new drug purchases bring on more debt, but also the possibilities of more/potential future earnings. Right now our biggest downside.
I fully expect, if any good news comes for Aralez for the stock to have a small bump up and then go lower then it was before that good news, that seems to be the pattern. I am ok with that. It is what it is..
Bio med/ Pharma, is in the dumps for now and it is cyclical cycle, lots to do with other dead weight companies, bringing this on to us, also the election and Hilary, etc..
But- Hege funds are like American Football teams,if you have success, you try to copy that pattern. Once this company starts making some real cash, the groups and hedgies are going to follow along..
I want to trust in Adams..
again- Just my two cents..

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities